@bugseq

We're empowering microbiology labs to prevent and treat infections with nucleic acid sequencing.

 Vancouver, Canada
bugseq.com
Joined April 2020
  • Tweets232
  • Following184
  • Followers203
59Media
Include

Only show posts containing:

Exclude

Hide posts containing:

Time range
-
Minimum likes
From targeted ITS sequencing direct from sample to WGS for outbreak strain typing: see how @nanopore and BugSeq enable rapid fungal pathogen characterisation. Register (offered in two time zones): nanoporetech.com/about/event…

A route to clinical fungal pathogen sequencing

Join this webinar to learn out about the advantages of targeted ITS and whole-genome sequencing approaches for potential clinical and epidemiological use.

nanoporetech.com
Oxford Nanopore
@nanoporeOct 6
Join researchers from Jessa Hospital and Tampa General Hospital who will share their clinical research workflow considerations, validation data, and implementation insights using nanopore sequencing and BugSeq analysis for fungal pathogen ID. bit.ly/4hgzpeS RUO
13
As metagenomic next-generation sequencing technology is increasingly used in clinical laboratories, BugSeq announces two new efforts to push mNGS technology towards regulated diagnostic use. Read the full details here: bugseq.com/news/2026/10/01/B…
1
60
Another great example from the team at @JessaZiekenhuis using BugSeq to analyze @nanopore sequencing data in routine clinical microbiology! doi.org/10.3389/fmicb.2026.1…
BugSeq@bugseqJul 29
.@JessaZiekenhuis, evaluating BugSeq for characterization of #AMR and outbreak analysis in Pseudomonas aeruginosa, found “the overall categorical agreement (% [95% CI]) between AMR genotype and phenotype was 94.76% [92.46%–96.52%]”. Read more: doi.org/10.1128/jcm.00572-26

Applicability of Nanopore-only whole-genome sequencing for Pseudomonas aeruginosa outbreak invest...

In recent years, Nanopore sequencing has found its way to clinical laboratories because of its affordability, scalability, and, most importantly, its ability to obtain sequencing results in near-real...

journals.asm.org
68
BugSeq retweeted
GenomeBC
@GenomeBCAug 7
New genomic tools are helping strengthen Canada's response to emerging pathogens and antimicrobial resistance. @techcouver @bugseq Read more: techcouver.com/2026/08/04/wi… #Genomics #PublicHealth #AMR #AntimicrobialResistance #InnovationBC
1
1
233
.@JessaZiekenhuis, evaluating BugSeq for characterization of #AMR and outbreak analysis in Pseudomonas aeruginosa, found “the overall categorical agreement (% [95% CI]) between AMR genotype and phenotype was 94.76% [92.46%–96.52%]”. Read more: doi.org/10.1128/jcm.00572-26

Applicability of Nanopore-only whole-genome sequencing for Pseudomonas aeruginosa outbreak invest...

In recent years, Nanopore sequencing has found its way to clinical laboratories because of its affordability, scalability, and, most importantly, its ability to obtain sequencing results in near-real...

journals.asm.org
1
90
Speed up your lab's #Cyclospora surveillance with the BugSeq platform. Contact us for early access to our new Cyclospora cayetanensis MLST module, which delivers typing from WGS and metagenomics!
34
We’re proud to team up with @GenomeBC on a new initiative to advance #Genomics in the fight against antimicrobial resistance! From scaling our #BugAMR platform to refining tools for rapid pathogen detection, we’re focused on one goal: faster, life-saving insights for healthcare.
GenomeBC
@GenomeBCJul 8
2 new research projects with BC-based biotech company @bugseq to advance genomic tools that improve antimicrobial resistance prediction and respiratory pathogen detection. Faster answers. Better treatment decisions. Stronger public health systems. genomebc.ca/?p=36516
1
34
linkedin.com/posts/daniel-na…

#asmicrobe | Daniel Navas

A huge thank you to everyone who stopped by my poster at #ASMicrobe 2026! It was great meeting so many people and discussing the future of Microbiology. Here is a closer look at this year's poster...

linkedin.com
25
Fantastic demonstration by the @AdventHealth team of the power of BugSeq in clinical practice: “Rapid and Routinely 24-Hour Antimicrobial Resistance Report for Mycobacterium abscessus Group by Whole-Genome Sequencing: A Tool for Appropriate Antimicrobial Therapy” 👇
1
1
45
Join BugSeq at ASM Microbe to see innovation in action! See the full BugSeq schedule, including demonstrations from our users: bugseq.com/resources/confere…
26
Check out recent updates to the BugSeq platform in our latest blog post: Advancing Viral Surveillance, Sequencing Flexibility, AMR Prediction, and EPI2ME Integration docs.bugseq.com/blog/2026/05…
1
1
58
Discover how public health laboratories are integrating BugSeq into their everyday bioinformatics routines! Visit us at booth 200 at @APHL 2026; we are eager to learn about the challenges you face and discuss how our solutions can support your work. #APHL
20
At #PASCV2026 ? Drop by the BugSeq booth (02T) to see how the most innovative labs are leveraging NGS to track viral outbreaks, antiviral resistance and more (and don’t forget to grab a notebook or bag)!
20
⏰ 16:15-17:15 CEST 📍 #Bioinformatics Pipeline Corner, Arena 4 🗣️ Sam Chorlton, BugSeq CEO See how we leverage interpretable AI to aid clinical translation and deliver industry-leading accuracy in: 🦠 Pathogen ID 💊 AMR prediction 📈 Outbreak analysis #ESCMIDGlobal2026
57
Miss the recent publication (doi.org/10.1128/jcm.01348-25) from @HopkinsMedicine leveraging BugSeq for infection control of C. auris? Stop by our booth at #SHEASpring2026 to learn how BugSeq powers genomic infection control programs.

Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole...

Candida auris is a difficult-to-treat yeast that causes invasive infections in vulnerable patient populations. Healthcare exposure is a key risk factor for becoming colonized or infected with C....

journals.asm.org
38
Load more